Analysts from Alembic Global and BMO Capital maintained Buy ratings on Chemours and Solstice Advanced Materials, with price targets of $22.00 and $95.00. The positive consensus signals optimism for th
BMO Capital reiterated its Buy rating on Solstice Advanced Materials and increased the price target to $95. The analyst firm cites a positive outlook regarding the company's future performance.
Solstice Advanced Materials stock rose 4.8% following Q2 2026 results with revenue up 11% to $1.148 billion and steady margins. While earnings were strong, investors remain cautious about high valuati
Solstice Advanced Materials shares rose 5.4% following its second-quarter earnings report on July 30, 2026. The company declared a $0.075 quarterly dividend while highlighting growth in nuclear, elect
RBC lowered its price target on Solstice Advanced Materials to $82 while maintaining an Outperform rating following positive Q2 earnings. Concurrently, UBS raised its target to $80 with a Buy rating.
Solstice Advanced Materials shares fell 35% despite strong earnings and an acquisition plan, yet remain overvalued with a P/E of 48.5x against a fair value of 23.5x. Analysts warn of integration risks
HSBC Holdings PLC increased its stake in Solstice Advanced Materials by 42.5% in Q1, acquiring 28,711 shares valued at approximately $7.29 million, while the company reported better-than-expected quar
Ferguson Wellman Capital Management Inc. reduced its stake in Solstice Advanced Materials by 94.1% in Q1. The company reported strong Q1 EPS of $0.63 and issued a quarterly dividend.
ChemBrief